Occlutechs latest product, muscular ventricular septal defect
(mVSD), received CE approval in 2015.
In a study conducted in Saudi Arabia, the most common echocardiographic findings in the infant of diabetic, were patent ductus arteriosus (PDA) in 70%, patent foramen ovale (PFO) in 68%, atrial septal defect (ASD) in 5%, small muscular ventricular septal defect
in 4%, mitral valve prolapse in 2%, and pulmonary stenosis in1% case respectively31.
3a), suggesting an area of infarction, and a muscular ventricular septal defect
(VSD) apical and inferior to this (Fig.
By two-dimensional transthoracic echocardiography (TTE) a very small muscular ventricular septal defect
Transcatheter closure of muscular ventricular septal defect occluder: Initial clinical application in children.
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder.
Intraoperative closure of muscular ventricular septal defect in a canine model and applicability of the technique in a baby.
Transcatheter closure of muscular ventricular septal defects
with the amplatzer ventricular septal defect occluder: Initial clinical applications in children.
Periventricular device closure of muscular ventricular septal defects
on the beating heart: technique and results.
However we still prefer to perform PA-banding for patients with multiple or apical muscular ventricular septal defects and also for patients with ventricular septal defect with complex extra cardiac congenital anomalies.
Muscular ventricular septal defects repaired with left ventriculotomy.
The types of defects found were as follows: absent coronary artery, enlarged coronary artery sinus, secundum-type atrial septal defects, aortic valve defect with fused leaflets creating aortic valvular stenosis, aortic valve defect with fenestrated leaflets, hypoplastic mitral valve annulus, hypoplastic tricuspid valve annulus, d-transposition, atrioventricular canal, and both membranous (subaortic) and muscular ventricular septal defects